Ompenaclid

N/A

Report date: 2024/04/29 11:39:09
NME

Base Information

Drug NameOmpenaclid
Drug Alias NameRGX-202RGX-202-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium- and chloride-dependent creatine transporter 1 inhibitors
TargetsSodium- and chloride-dependent creatine transporter 1
Therapy Area/IndicationsStomach NeoplasmsColonic NeoplasmsColorectal Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesInspirna Inc
China Registration ClassN/A

Develop Information

Active CompaniesInspirna IncMerck KGaA, Darmstadt, Germany
Inactive CompaniesN/A
Active IndicationsStomach NeoplasmsColonic NeoplasmsColorectal Neoplasms +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A